Showing results (1031-1040 of 3,525) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|July 20, 2017
Primary pulmonary myxoid sarcoma located in interlobar fissure without parenchymal invasionSeok Kim, Sang Yun Song, Ju Sik Yun, et al.
Thoracic Cancer|September 12, 2017
Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinomaCong-Min Liu, Di Liang, Jing Jin, et al.
Thoracic Cancer|September 8, 2017
Case series of pleomorphic carcinomas of the lung treated with nivolumabMasaki Kanazu, Takeshi Uenami, Yukihiro Yano, et al.
Thoracic Cancer|May 6, 2016
Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resectionWenpeng Jiang, Zhou Wang, Gang Chen, et al.
Thoracic Cancer|May 6, 2016
Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cellsShizhao Cheng, Yue Xu, Zhenliang Shi, et al.
Thoracic Cancer|October 25, 2017
Remarkable response of nivolumab-refractory lung cancer to salvage chemotherapyDaiki Ogawara, Hiroshi Soda, Keisuke Iwasaki, et al.
Thoracic Cancer|April 28, 2022
Balloon dilatation complications during esophagogastric anastomotic stricture treatment under fluoroscopy: Risk factors, prevention, and managementShuai Wang, Xiaobing Li, Chenchen Zhang, et al.
Thoracic Cancer|April 30, 2022
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, et al.
Thoracic Cancer|May 2, 2022
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterationsYuji Uehara, Kageaki Watanabe, Taiki Hakozaki, et al.
Thoracic Cancer|May 3, 2022
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited countrySoon Hin How, Lye Mun Tho, Chong Kin Liam, et al.
Pageof 353